Gabapentin decreases the severity of dystonia at low doses in a genetic animal model of paroxysmal dystonic choreoathetosis

European Journal of Pharmacology

Volumn 369, Issue 3, 1999, Pages 335-338

  Richter, Angelika ^a   Löscher, Wolfgang ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Dyskinesia; Dystonia; GABA ( aminobutyric acid); Movement disorder

Indexed keywords

GABAPENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOREOATHETOSIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MECHANISM; DYSTONIA; GABAERGIC SYSTEM; GENETIC DISORDER; HAMSTER; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL;

ACETIC ACIDS; AMINES; ANIMALS; ANTICONVULSANTS; CRICETINAE; CYCLOHEXANECARBOXYLIC ACIDS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSTONIA; EXCITATORY AMINO ACID ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID;

EID: 0345059303     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00104-1     Document Type: Article

References (20)

1. Chudnow R.S., Dewey R.B., Lawson C.R. Choreoathetosis as a side effect of gabapentin therapy in severely neurologically impaired patients. Arch. Neurol. 54:1997;910-912.
2. Chudnow R.S., Mimbela R.A., Owen D.B., Roach E.S. Gabapentin for familial paroxysmal dystonia choreoathetosis. Neurology. 49:1997;1441-1442.
3. Corey A., Koller W. Phenytoin-induced dystonia. Ann. Neurol. 14:1983;92. Letter.
4. Demirkiran M., Jankovic J. Paroxysmal diskinesias: clinical features and classification. Ann. Neurol. 38:1995;571-579.
5. Fouad G., Servidei S., Durcan S., Bertini E., Ptacek L.J. A gene for familial paroxysmal dyskinesia (FPD1) maps to chromosome 2q. Am. J. Hum. Genet. 59:1996;135-139.
6. Frost M.D., Ritter F.J., Hoskin C., Mims J., Espe-Lillo J. Movement disorder associated with lamotrigine treatment in children and adolescents. Epilepsia. 37(5):1996;112. Suppl.
7. Löscher W., Fisher J.E. Jr., Schmidt D., Fredow G., Hönack D., Iturrian W.B. The sz mutant hamster: a genetic model of epilepsy or of paroxysmal dystonia? Mov. Dis. 4:1989;219-232.
8. Löscher W., Hönack D., Taylor C.P. Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several brain regions of rat brain. Neurosci. Lett. 128:1991;150-154.
9. Ramsey, R.E., 1995. Gabapentin: toxicity. In: Levy, R.H., Mattson, R.H., Meldrum, B.S. (Eds.), Antiepileptic Drugs. Raven Press, New York, pp. 857-860.
10. sz) hamster: evidence for enhanced striatal dopaminergic activity found by pharmacological manipulations. Soc. Neurosci. Abstr. 24:1998;660.
11. Reimann W. Inhibition by GABA, baclofen and gabapentin of dopamine release from rabbit caudate nucleus: are there common or different sites of action? Eur. J. Pharmacol. 94:1983;341-344.
12. 2+ channel antagonists in a hamster model of idiopathic dystonia. Eur. J. Pharmacol. 300:1996;197-202.
13. Richter A., Löscher W. Pathophysiology of idiopathic dystonia: findings from genetic animal models. Prog. Neurobiol. 54:1998;633-677.
14. Richter A., Fredow G., Löscher W. Antidystonic effects of the NMDA receptor antagonists memantine, MK-801 and CGP 37849 in a hamster model of paroxysmal dystonia. Neurosci. Lett. 133:1991;57-60.
15. Richter A., Löscher W., Löschmann P.-A. The AMPA receptor antagonist NBQX exerts antidystonic effects in an animal model of idiopathic dystonia. Eur. J. Pharmacol. 231:1993;287-291.
16. Richter A., Löschmann P.-A., Löscher W. The novel antiepileptic drug lamotrigine exerts prodystonic effects in a mutant hamster model of generalized dystonia. Eur. J. Pharmacol. 264:1994;345-351.
17. Richter A., Gernert M., Löscher W. Prodystonic effects of riluzole in an animal model of idiopathic dystonia related to decreased total power in the red nucleus? Eur. J. Pharmacol. 332:1997;133-142.
18. Taylor C.P., Gee N.S., Su T.Z., Kocsis J.D., Welty D.F., Brown J.P., Dooley D.J., Boden P., Singh L. A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res. 29:1998;233-249.
19. Wamill A.W., McLean M.J. Limitation by gabapentin of high frequency action potential firing by mouse central neurons in cell culture. Epilepsy Res. 17:1994;1-11.
20. Welty D.F., Wang Y., Busch J.A., Taylor C.P., Vartanian M.G., Radulovic L.L. Pharmacokinetics and pharmacodynamics of CI-1008 (pregabalin) and gabapentin in rats using maximal electroshock. Epilepsia. 38:1997;35-36. abstract.